Pharmacological management of rare coagulation factor deficiencies besides hemophilia

Expert Rev Hematol. 2020 Aug;13(8):811-834. doi: 10.1080/17474086.2020.1796622. Epub 2020 Oct 6.

Abstract

Introduction: Rare coagulation factor deficiencies are less-known disorders with variable effects on the patient's life. Management of such patients is a challenge due to the paucity of evidence-based data, more so when patients with these rare disorders encounter a more rare, related condition, like inhibitor development or thrombosis.

Area covered: A comprehensive literature search related to RCFDs and management was performed in PubMed in order to discuss therapeutic options and challenges, prophylaxis, management of minor and major surgeries, obstetric and gynecological complications, inhibitor development, and thrombosis.

Expert opinion: Although significant changes have occurred in the management of RCFDs in recent years, more evidence-based studies besides expert opinion are needed for optimal management.

Keywords: Rare coagulation factor deficiencies; bleeding; management; prophylaxis; surgery.

Publication types

  • Meta-Analysis
  • Review

MeSH terms

  • Biomarkers
  • Blood Coagulation / drug effects
  • Blood Coagulation Factors / genetics
  • Blood Coagulation Factors / therapeutic use
  • Coagulation Protein Disorders / diagnosis
  • Coagulation Protein Disorders / drug therapy*
  • Coagulation Protein Disorders / etiology*
  • Coagulation Protein Disorders / prevention & control
  • Combined Modality Therapy
  • Disease Management
  • Disease Susceptibility
  • Female
  • Humans
  • Pregnancy
  • Pregnancy Complications, Hematologic / diagnosis
  • Pregnancy Complications, Hematologic / drug therapy
  • Pregnancy Complications, Hematologic / etiology
  • Prognosis
  • Rare Diseases / diagnosis
  • Rare Diseases / drug therapy*
  • Rare Diseases / etiology*
  • Rare Diseases / prevention & control
  • Treatment Outcome

Substances

  • Biomarkers
  • Blood Coagulation Factors